Fifth MENA Congress for Rare Diseases Opens in Abu Dhabi
The Fifth MENA Congress for Rare Diseases opens in Abu Dhabi with…
$27.7 Million Project to Advance Gene-Editing Therapies for Rare Immune Diseases
Mayo Clinic joins a $27.7 million ARPA-H project using CRISPR gene editing…
Abu Dhabi enhances International life sciences cooperation and investment opportunities
Abu Dhabi’s Department of Health has partnered with Biocom California to establish…
Advancing Sickle Cell Cure in Africa: Transplant & Gene Therapy | Dr. Lawrence Faulkner | BMT
Advances in transplant medicine and gene editing are reshaping the future of…
Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk
Eli Lilly and Company and Verve Therapeutics, Inc., a Boston-based clinical-stage company…
Two Days to Go, London Biotechnology Show 2025 Gears Up to Spotlight Industry Pioneers, DisruptiveTech, Emerging Innovators
In just two days, the second edition of the London Biotechnology Show…
